Paediatric Consumer Health in Japan
PAEDIATRIC CONSUMER HEALTH IN JAPAN
Euromonitor International
February 2019
LIST OF CONTENTS AND TABLES
Headlines
Prospects
the Decrease in the Child Population Leads To Decline
Paediatric Consumer Health Products Are Highly Regarded Amongst Inbound Tourists
Shift To Include Consumption by Both Children and Adults
Competitive Landscape
Hisamitsu Pharmaceutical Enters Paediatric Allergy Remedies
Demand Is Strong for Prescribed Medicine, With Support From Municipalities
Category Data
Table 1 Sales of Paediatric Consumer Health by Category: Value 2013-2018
Table 2 Sales of Paediatric Consumer Health by Category: % Value Growth 2013-2018
Table 3 Sales of Paediatric Vitamins and Dietary Supplements by Type: % Value 2015-2018
Table 4 NBO Company Shares of Paediatric Consumer Health: % Value 2014-2018
Table 5 LBN Brand Shares of Paediatric Consumer Health: % Value 2015-2018
Table 6 Forecast Sales of Paediatric Consumer Health by Category: Value 2018-2023
Table 7 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2018-2023
Executive Summary
the Healthy Living Mindset Spreads, Leading To Growth in Sports Nutrition
Disappointing Impact of the New Tax System on OTC Products
Players Offering Switched OTC Products Enjoy Growth
Internet Retailing Rises, Whilst Drugstores/parapharmacies Continues To Lead
Continued Growth Is Expected, As Consumers' Health Concerns Rise
Market Indicators
Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018
Table 9 Life Expectancy at Birth 2013-2018
Market Data
Table 10 Sales of Consumer Health by Category: Value 2013-2018
Table 11 Sales of Consumer Health by Category: % Value Growth 2013-2018
Table 12 NBO Company Shares of Consumer Health: % Value 2014-2018
Table 13 LBN Brand Shares of Consumer Health: % Value 2015-2018
Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2013-2018
Table 15 Distribution of Consumer Health by Format: % Value 2013-2018
Table 16 Distribution of Consumer Health by Format and Category: % Value 2018
Table 17 Forecast Sales of Consumer Health by Category: Value 2018-2023
Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Summary 1 OTC: Switches
Sources
Summary 2 Research Sources
The continuing decline in the birth rate in Japan negatively impacted paediatric consumer health throughout the review period. In 2018, the population aged 0-14 was 6% lower compared with in 2013, accounting for 12% of the total population in Japan. In the forecast period to 2023, the child population is expected to decrease further. In such a situation, paediatric consumer health faces challenges expanding, as the category has already passed maturity and is now entering a phase of declining dem...
Euromonitor International's Paediatric Consumer Health in Japan report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.
Product coverage: Nappy (Diaper) Rash Treatments, Paediatric Analgesics, Paediatric Cough, Cold and Allergy Remedies, Paediatric Dermatologicals, Paediatric Digestive Remedies, Paediatric Vitamins and Dietary Supplements.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Paediatric Consumer Health market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.